Novel Approach to Improve the Identification of the Bleeding Phenotype in Noonan Syndrome and Related RASopathies
- PMID: 36646249
- DOI: 10.1016/j.jpeds.2022.12.036
Novel Approach to Improve the Identification of the Bleeding Phenotype in Noonan Syndrome and Related RASopathies
Abstract
Objectives: To characterize the bleeding phenotype in Noonan syndrome (NS), to test the utility of following national guidelines in detecting this phenotype, to evaluate thromboelastography (TEG) as a diagnostic tool, and to evaluate the cohort for genotype-phenotype correlations.
Study design: Participants with a clinical diagnosis of NS or related RASopathies were enrolled in a cohort study. Study procedures included clinical bleeding assessment, coagulation testing per guidelines, and hematology consultation. TEG was completed in a subset, and genetic testing was conducted for those without a molecular diagnosis. International Society of Haemostasis and Thrombosis Bleeding Assessment Tool scores were calculated with hematology consultation. Bleeding phenotype was defined as abnormal bleeding score.
Results: Twenty participants were enrolled; 12 completed clinical and laboratory evaluation, and five of whom met the definition for bleeding phenotype. Four of the five participants with a bleeding phenotype had platelet aggregation defects and at least one additional coagulation defect. TEG was performed in nine participants, four with bleeding phenotype and five without, and results were normal in all cases. No genotype-phenotype correlation was found.
Conclusion: Five of the 20 participants had a bleeding phenotype identified. Based on available data, we do not recommend incorporating TEG into clinical practice for patients with NS. Platelet aggregation defects were the most common abnormalities, which would not be detected on tier 1 testing of current guidelines; therefore, we propose a new algorithm.
Keywords: bleeding disorders; screening recommendations.
Copyright © 2023 Elsevier Inc. All rights reserved.
Similar articles
-
RASopathies and hemostatic abnormalities: key role of platelet dysfunction.Orphanet J Rare Dis. 2021 Dec 2;16(1):499. doi: 10.1186/s13023-021-02122-7. Orphanet J Rare Dis. 2021. PMID: 34857025 Free PMC article.
-
Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype.Haemophilia. 2015 Jan;21(1):124-32. doi: 10.1111/hae.12481. Haemophilia. 2015. PMID: 25545302 Review.
-
Relationship of thromboelastography and conventional clotting test values with severe bleeding in critically ill patients with coagulopathy: A prospective study.Int J Lab Hematol. 2019 Oct;41(5):671-678. doi: 10.1111/ijlh.13086. Epub 2019 Aug 12. Int J Lab Hematol. 2019. PMID: 31403249
-
Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs.Vet J. 2009 Jan;179(1):121-9. doi: 10.1016/j.tvjl.2007.08.022. Epub 2007 Oct 24. Vet J. 2009. PMID: 17920966
-
Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2015 Jul;19(58):1-228, v-vi. doi: 10.3310/hta19580. Health Technol Assess. 2015. PMID: 26215747 Free PMC article. Review.
Cited by
-
Co-Occurring Thrombotic Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia in a Child Carrying the Pathogenic SHOC2 c.4A>G (p.Ser2Gly) Variant.Am J Case Rep. 2023 Nov 29;24:e942377. doi: 10.12659/AJCR.942377. Am J Case Rep. 2023. PMID: 38019730 Free PMC article.
-
The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.Am J Med Genet A. 2024 Apr;194(4):e63477. doi: 10.1002/ajmg.a.63477. Epub 2023 Nov 15. Am J Med Genet A. 2024. PMID: 37969032
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous